Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2020 | 12-2019 | 04-2019 | 12-2018 | 04-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,410 | N/A | -4,863 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | -37 | N/A | N/A |
| Other Working Capital | -191 | N/A | 1,230 | N/A | N/A |
| Other Operating Activity | 2,255 | 0 | 2,624 | 0 | 0 |
| Operating Cash Flow | $-2,346 | $N/A | $-1,045 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 105 | 0 | 234 | 0 | 0 |
| Investing Cash Flow | $105 | $N/A | $234 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -17 | N/A | 73 | N/A | N/A |
| Debt Issued | 17 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,288 | N/A | 236 | N/A | N/A |
| Financing Cash Flow | $2,289 | $N/A | $309 | $N/A | $N/A |
| Beginning Cash Position | 43 | N/A | 545 | N/A | N/A |
| End Cash Position | 90 | N/A | 43 | N/A | N/A |
| Net Cash Flow | $48 | $N/A | $-502 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,346 | N/A | -1,045 | N/A | N/A |
| Free Cash Flow | -2,346 | 0 | -1,045 | 0 | 0 |